288 related articles for article (PubMed ID: 35884166)
1. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
Horowitz RI; Freeman PR
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884166
[TBL] [Abstract][Full Text] [Related]
2. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review.
Horowitz RI; Fallon J; Freeman PR
Microorganisms; 2024 Apr; 12(5):. PubMed ID: 38792737
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections.
Horowitz RI; Fallon J; Freeman PR
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764145
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review.
Horowitz RI; Freeman PR
Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33105645
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1.
Horowitz RI; Freeman PR
Int J Gen Med; 2019; 12():101-119. PubMed ID: 30863136
[TBL] [Abstract][Full Text] [Related]
6. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.
Horowitz RI; Murali K; Gaur G; Freeman PR; Sapi E
BMC Res Notes; 2020 Sep; 13(1):455. PubMed ID: 32993780
[TBL] [Abstract][Full Text] [Related]
7. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
[TBL] [Abstract][Full Text] [Related]
8. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
[TBL] [Abstract][Full Text] [Related]
9. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime.
Feng J; Weitner M; Shi W; Zhang S; Zhang Y
Front Microbiol; 2016; 7():62. PubMed ID: 26903956
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2.
Horowitz RI; Freeman PR
Healthcare (Basel); 2018 Nov; 6(4):. PubMed ID: 30400667
[TBL] [Abstract][Full Text] [Related]
13. Treatment of post-treatment Lyme disease symptoms-a systematic review.
Dersch R; Torbahn G; Rauer S
Eur J Neurol; 2024 Jul; 31(7):e16293. PubMed ID: 38606630
[TBL] [Abstract][Full Text] [Related]
14. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
15. Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.
Shor S; Green C; Szantyr B; Phillips S; Liegner K; Burrascano JJ; Bransfield R; Maloney EL
Antibiotics (Basel); 2019 Dec; 8(4):. PubMed ID: 31888310
[No Abstract] [Full Text] [Related]
16. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
Rebman AW; Bechtold KT; Yang T; Mihm EA; Soloski MJ; Novak CB; Aucott JN
Front Med (Lausanne); 2017; 4():224. PubMed ID: 29312942
[TBL] [Abstract][Full Text] [Related]
17. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
Wong KH; Shapiro ED; Soffer GK
Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
[TBL] [Abstract][Full Text] [Related]
18. Persistent Symptoms After Treatment of Lyme Disease.
Marques A
Infect Dis Clin North Am; 2022 Sep; 36(3):621-638. PubMed ID: 36116839
[TBL] [Abstract][Full Text] [Related]
19. Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro.
Feng J; Zhang S; Shi W; Zhang Y
Antibiotics (Basel); 2017 Mar; 6(1):. PubMed ID: 28327498
[TBL] [Abstract][Full Text] [Related]
20. Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome.
Sloupenska K; Koubkova B; Horak P; Hutyrova B; Racansky M; Mares J; Miklusova M; Schovanek J; Zapletalova J; Raska M; Krupka M
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
